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Abstract
Background: The scale-up of evidence-based innovations is required to reduce waste and inequities in health and
social services (HSS). However, it often tends to be a top-down process initiated by policy makers, and the values of
the intended beneficiaries are forgotten. Involving multiple stakeholders including patients and the public in the
scaling-up process is thus essential but highly complex. We propose to identify relevant strategies for meaningfully
and equitably involving patients and the public in the science and practice of scaling up in HSS.
Methods: We will adapt our overall method from the RAND/UCLA Appropriateness Method. Following this, we will
perform a two-prong study design (knowledge synthesis and Delphi study) grounded in an integrated knowledge
translation approach. This approach involves extensive participation of a network of stakeholders interested in
patient and public involvement (PPI) in scaling up and a multidisciplinary steering committee. We will conduct a
systematic scoping review following the methodology recommended in the Joanna Briggs Institute Reviewers
Manual. We will use the following eligibility criteria: (1) participants—any stakeholder involved in creating or testing
a strategy for PPI; (2) intervention—any PPI strategy proposed for scaling-up initiatives; (3) comparator—no
restriction; (4) outcomes: any process or outcome metrics related to PPI; and (5) setting—HSS. We will search
electronic databases (e.g., Medline, Web of Science, Sociological Abstract) from inception onwards, hand search
relevant websites, screen the reference lists of included records, and consult experts in the field. Two reviewers will
independently select and extract eligible studies. We will summarize data quantitatively and qualitatively and report
results using the PRISMA extension for Scoping Reviews (PRISMA-ScR) checklist. We will conduct an online Delphi
survey to achieve consensus on the relevant strategies for PPI in scaling-up initiatives in HSS. Participants will
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include stakeholders from low-, middle-, and high-income countries. We anticipate that three rounds will allow an
acceptable degree of agreement on research priorities.
Discussion: Our findings will advance understanding of how to meaningfully and equitably involve patients and
the public in scaling-up initiatives for sustainable HSS.
Systematic review registration: We registered this protocol with the Open Science Framework on August 19,
2020 (https://osf.io/zqpx7/).
Keywords: Patient and public involvement, Scaling up, Spread, Scaling science, Health and social services, Implementation
science, Knowledge translation, Strategy
Background
There is widespread enthusiasm for the use of ideas, prac-
tices, or products perceived as new (i.e., innovations) and for
which an evidence base has been established (i.e., evidence-
based innovations) in order to improve health and social ser-
vices (HSS) [1, 2]. The impact of evidence-based innovations
(EBIs) should be optimized to reduce waste and inequities in
HSS and improve the health of populations [3, 4]. But evi-
dence is limited on how to implement EBIs so that they
benefit more patients or a broader spectrum of pa-
tients in healthcare systems [5]. For example, there is
a shortage of evidence on strategies for expanding or
“scaling up” EBIs [6]. In knowledge translation (KT)
and implementation science (both hereafter referred
to as KT), the differences between “scaling up,” “scal-
ing out,” “scaling deep,” “scaling,” and “spread” are
variously nuanced [5–7]. Here, we use the term “scal-
ing up” or “scale up,” which is more familiar to lay
knowledge users (e.g., patients and the public). The
World Health Organization defines the process of
“scaling up” as “deliberate efforts to increase the im-
pact of successfully tested health innovations so as to
benefit more people and to foster policy and program
development on a lasting basis” [8]. Here, we under-
stand scaling up to optimize equity, for example, as
enlarging the scope of EBI not only numerically but
also in other respects, e.g., increasing its range to a
wider variety of socio-economic backgrounds [5].
While anticipating scaling up should begin at the
earliest stages of research [5, 9], we summarized the
main scaling-up steps as follows [1]: (1) scalability as-
sessment, (2) development of a scaling-up strategy, (3)
implementation and evaluation of the strategy, and (4)
promoting the long-term sustained use of the success-
fully scaled-up EBI. The scalability assessment, the
preliminary and essential step in scaling up an EBI, re-
fers to assessment of the “ability of a health innovation
shown to be efficacious on a small scale and/or under
controlled conditions to be expanded under real world
conditions to reach a greater proportion [or range] of
the eligible population, while retaining effectiveness”
[5, 10].
Just as the scaling up of EBIs remains an under-
studied phase of KT [11, 12], the science and practice
of scaling up, in turn, has not yet fully integrated
patient-oriented research principles [6, 7]. Our previ-
ous knowledge synthesis shows that barriers to scaling
up EBIs include an absence of patient and public in-
volvement (PPI) [6]. Scaling up often tends to be a
top-down process initiated by policy makers and/or
researchers [6, 7]. The values, preferences, and per-
spectives of the intended beneficiaries, i.e., the pa-
tients and public, are often forgotten. As patients and
the public are at the core of healthcare systems that
serve them, it is essential that they be part of the
scaling up of such systems [13, 14], including pre-
paratory, execution, and translational phases [15]. Not
only should they be involved, but their involvement
should be meaningful and equitable, i.e., it should be
more than tokenistic, and their input should carry
equal weight as that of policy makers and researchers.
Strengthening patient and public influence on health
decisions at every level is a necessary condition for a
continuously learning health care system [16, 17].
However, policy makers and researchers who want to
involve lay participants in this domain dominated by
experts face a multiple of challenges, which need to
be addressed.
In this research, we aim to address this knowledge gap
in KT by building patient-oriented research capacity in
the science and practice of scaling up in HSS, by ensur-
ing that patients and the public are meaningfully and
equitably involved. Therefore, our research question is:
“How can patients and the public be meaningfully and
equitably involved in scaling-up initiatives in HSS?” Our
specific objectives are to (1) review existing literature on
PPI in any scaling-up initiative in HSS; (2) achieve con-
sensus on relevant strategies for involving patients and
the public at each scaling-up step in HSS; and (3) build
an international network of interest in the involvement
of patients, the public, and other stakeholders in the sci-
ence and practice of scaling up in HSS. This effort will
contribute to an evidence-driven and people-centered
science of scaling up.
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Methods
Overarching methodological approach
We will adapt our overall method from the RAND/
UCLA Appropriateness Method [18, 19]. Following this,
our research will entail a two-prong study design: (1) a
knowledge synthesis and (2) a Delphi study. We will use
the Canadian Institutes of Health Research (CIHR) guid-
ance to integrate considerations of sex and gender [20]
into both the knowledge synthesis and the Delphi study.
Our project is grounded in an integrated KT (iKT) ap-
proach and thus involves extensive participation of (1) a
network of stakeholders interested in PPI in scaling up,
the Research on Patient-Oriented Scaling-up (RePOS)
Network, and (2) a multidisciplinary steering committee.
The latter will include at least two patients or citizens,
one policy- or decision-maker, one health care provider,
one researcher, one scientific coordinator, and one
trainee. We will use the CIHR Model of Knowledge
Translation [21], the Montreal model [14], and the Pub-
lic and Patient Engagement Evaluation Tool (PPEET)
[22] to guide and assess our iKT approach. Finally, to
ensure accurate and transparent reporting of this iKT
approach, we will report evaluations using the Guidance
for Reporting Involvement of Patients and the Public
(GRIPP2) checklist [23] and the Sex and Gender Equity
in Research (SAGER) guidelines [24].
Knowledge synthesis
Study design
We will conduct a scoping review to identify strategies
that have been proposed for involving patients and the
public in the science or practice of scaling up innovations
in HSS. Scoping reviews are defined as a type of know-
ledge synthesis that follows a systematic approach to map
evidence on a topic and identify main concepts, theories,
sources, and knowledge gaps [25]. We will follow the
methodology recommended in the Joanna Briggs Institute
(JBI) Reviewers’ Manual for scoping reviews [26, 27] and
have registered the protocol in the Open Science Frame-
work (OSF) on August 19, 2020 (registration identifier:
https://osf.io/zqpx7/) [28]. We report the content for this
scoping review protocol using the Preferred Reporting
Items for Systematic reviews and Meta-Analyses Protocol
(PRISMA-P) checklist (Additional file 1) [29].
Eligibility criteria
Following the “PICOS” (participants, intervention, com-
parator, outcome, and setting) framework [30], we will
use the following inclusion criteria:
▪ Participants (P): Any type of stakeholder involved in
creating or testing a strategy for PPI in the science or
practice of scaling up. Stakeholder refers to “individual or
group who is responsible for or affected by health- and
healthcare-related decisions that can be informed by
research evidence” [31, 32]. We will include the following
nine types of stakeholders: (1) patients and the public (e.g.,
patients, their informal caregivers, their families, patient
and consumer advocacy organizations, and local, national,
or global citizens), (2) providers (e.g., individuals and
organizations that provide care to patients and
populations such as nurses, physicians, pharmacists,
mental health counselors, and community-based workers),
(3) purchasers (e.g., employers, governments, and other
individuals or entities responsible for underwriting the
cost of care), (4) payers (e.g., payers who pay or reimburse
costs of health-related interventions such as insurers,
individuals with deductibles, and others responsible for
reimbursement for health-related\ interventions), (5)
policy makers (e.g., policymaking entities such as
governments and professional associations), (6) product
makers (e.g., drug and device manufacturers), (7)
investigators (e.g., researchers, postdoctoral fellows,
and research coordinators), (8) the press (e.g., publishers
and news media), and (9) trainees (e.g., university or
college students) [31–34]. This includes organizations that
provide guidance for promoting PPI in the science and
practice of scaling up in HSS.
▪ Intervention (I): Any strategy proposed for involving
patients and/or the public (alone) or multiple
stakeholders (including patients and/or the public) in
research or practical initiatives related to the steps of the
scaling-up process in HSS. We will consider the four
levels of PPI [13, 14]: (1) information (i.e., patient or the
public receives information but has no role in
contributing); (2) consultation (i.e., patients or the public
provide their views, thoughts, feedback, opinions, or
experiences but without a commitment to act on them;
(3) collaboration (i.e., patients or the public are engaged
to influence the scaling-up initiative, including
commenting, advising, ranking, voting, prioritizing, and
reaching consensus, but without direct control over
decisions; and (4) coproduction (i.e., patients or the
public are equal members of the research team and
participate in all steps of the scaling-up initiative).
▪ Comparator (C): We will consider for inclusion both
studies with comparison group and studies without.
▪ Outcomes (O): We will consider a wide range of
metrics related to PPI. We will use the following
taxonomy: process metrics and outcome metrics [35].
The process metrics form four domains: (1) direct
process metrics (e.g., agenda setting and time
allocation, roles in decision making, and control over
the meeting minutes); (2) surrogate process metrics
(e.g., formal power, organizational commitment to
involvement, and equality of participation); (3)
preconditions for involvement metrics (e.g., literacy of
patient and public participants, resources provided, and
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presence or quality of training); and (4) aggregate
process metrics (e.g., respect, transparency of the
decision-making process, and level or ladder of partici-
pation). The outcome metrics form three domains: (1)
internal outcomes as measured by impact on involved
patient or public participants (e.g., knowledge, satisfac-
tion, and trust), on services provided (e.g., efficiency
and cost-effectiveness of services, number of complaints
about services, and services quality and safety), and on
organization or system (e.g., funding and resources
availability, staff views on PPI, and presence of racism
in system); (2) external outcomes as measured by influ-
ence on the broader public (e.g., awareness or know-
ledge of health issues, support of the organization or
system, and PPI as part of social change outside the
organization), and on population health (e.g., popula-
tion health status and level of health inequalities); and
(3) aggregate outcomes (e.g., overall cost-effectiveness
of PPI).
▪ Setting (S): Any context related to HSS. The World
Health Organization defines health as “a state of
complete physical, mental and social well-being and not
merely the absence of disease or infirmity” [36].
Literature search
We will perform a comprehensive search for both pub-
lished peer-reviewed records and “grey literature”
through searching electronic databases, hand searching
relevant websites, screening the reference lists of in-
cluded records, and consulting experts in the field. First,
we will search Medline, EMBASE, Web of Science,
CINAHL, PsycINFO, ERIC, the Cochrane Library, Socio-
logical Abstract, and Academic Search Premier from
their inception onwards. Our information specialist will
perform the electronic search strategy in Medline. The
search terms will reflect the concepts: (1) PPI, (2) scaling
up, and (3) HSS. These terms will be adapted to the
above-mentioned databases. There will be no restriction
with regard to language, date of publication, or type of
document. This strategy will be reviewed by our inter-
national authors, experts on scaling up, and stakeholder
involvement, then by a second information specialist
using the Peer Review of Electronic Search Strategies
(PRESS) guideline [37]. A draft of the search strategy
can be found in Additional file 2. Second, we will consult
the “grey literature” involving general and targeted Inter-
net searches. This approach is promoted by the Agency
for Healthcare Research and Quality (AHRQ) as a way
of reducing publication bias [38]. Grey literature consists
of unpublished literature, including publicly available in-
formation produced by all levels of government, aca-
demic institutions, business, and industry, in print and
electronic formats, which is not controlled by commer-
cial publishers [39–41]. For the general search, we will
enter various configurations of a search term list into
Google. For the targeted search, we will examine web-
sites of the national and international organizations rec-
ommended by our steering committee and by other
international scaling-up experts. Additionally, we will
use the approach recommended by the Canadian Agency
for Drugs and Technologies in Health (CADTH) for sys-
tematic searches of grey literature [42]. Finally, we will
search published bibliographies of related topics and ci-
tations in included articles and consult experts in the
field to identify additional relevant studies.
Study selection
We will operationalize our inclusion criteria using ques-
tions based on our PICOS elements. Two reviewers will
perform a calibration exercise to ensure the criteria cap-
ture relevant studies. They will also independently screen
titles and abstracts of a random sample of 5% of studies
identified with our literature search. We will discuss the
results of this pilot and review the eligibility criteria. We
will check inter-reviewer agreement between these re-
viewers using the kappa statistic. Then, two reviewers will
independently screen all remaining titles and abstracts for
relevance, procure full texts of relevant studies, and select
eligible studies. We will resolve any disagreements
through consensus between the two reviewers and, if
needed, with a third party. We will use the Covidence
software for the selection of titles and abstracts [43]. Eli-
gible studies will be exported into an Excel spreadsheet.
Data extraction
First, we will develop a data-charting form to guide ex-
traction of variables based on the Montreal model [14],
which is an adapted version of the framework for patient
and family engagement in health [13]. The data-charting
form will include the PICOS elements and “PROGRESS”
(place of residence, race/ethnicity/culture/language, oc-
cupation, gender/sex, religion, education, socioeconomic
status, and social capital) factors [44]. Second, two re-
viewers will perform a calibration exercise to guide se-
lection of evidence sources to ensure the form captures
all relevant data. Then, they will independently extract
data from some included studies using the data-charting
form and meet the steering committee members to de-
termine whether the approach to data extraction is con-
sistent with the research question and purpose. Third,
we will separately extract strategies used for involving
(1) patients and/or the public (alone) and (2) multiple
stakeholders including patients and/or the public. We
will also separately extract strategies used for women
(e.g., for scaling up a prenatal screening program) from
those used for men (e.g., for scaling up a prostate cancer
program), and other sex- or gender-specific strategies.
Finally, we will resolve any disagreements through
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consensus between the two reviewers and, if needed, with
a third party. We will contact authors of included studies
to provide missing or additional data if necessary.
Risk of bias
We will not perform an appraisal for risk of bias. Due to
the nature of our research question, assessing risk of bias
is not mandatory, according to the Joanna Briggs Insti-
tute Reviewers’ Manual [27, 45].
Data analysis
We will summarize data quantitatively (using frequen-
cies) and qualitatively (drawing on the descriptive analyt-
ical method) to describe PPI strategies in scaling-up
initiatives in HSS. We will structure the data on the in-
cluded studies according to the PICOS elements and
PROGRESS factors. We anticipate that the development
of a quantitative meta-analysis will not be feasible due to
the nature of our research question and substantial
methodological heterogeneity of studies identified. If
possible, we will stratify results by (1) economic status of
the country (e.g., low-, middle-, or high-income coun-
try), (2) sex/gender, and (3) health context (e.g., primary
care, secondary, and tertiary care). We will report our
results using the Preferred Reporting Items for System-
atic reviews and Meta-Analyses extension for Scoping
Reviews (PRISMA-ScR) checklist [25], the SAGER
guidelines [24], and the GRIPP2 reporting checklist [23].
Consultation with the steering committee
Our steering committee will seek consensus on a prelim-
inary set of PPI strategies to present in an online Delphi
(e-Delphi) survey. First, we will provide the committee
with a list of the PPI strategies found in the literature.
Each steering committee member will review the inven-
tory and judge whether the PPI strategy represents the
construct of PPI or not. Second, the project leaders will
produce a comprehensive list of voted PPI strategies.
Third, a videoconference will be conducted to reach a
decision about which PPI strategies will be included in a




As part of the RAND/UCLA Appropriateness Method
[18, 19], we will use evidence from the knowledge syn-
thesis to achieve a consensus opinion on the relevant
PPI strategies for scaling-up initiatives in HSS.
Participants
Based on sampling trends and recommendations from
previous Delphi studies, we aim to invite 100 participants
[46] to help ensure that a minimum of 16 stakeholders
complete all the rounds [47]. We will include at least four
patients or citizens (men and women), two health care
providers, two policy or decision makers, two trainees,
two members of patient-oriented research organizations,
two scaling-up researchers, and two first or last authors of
scaling-up studies. We will include them according to (1)
their age (at least 18 years old); (2) their ability to partici-
pate, read, and understand English or French; and (3) their
knowledge or interest in the field. We plan to recruit
participants through the directed snowball method. We
will ensure patients and citizens understand our research
objectives and participate in decisions as we prepare and
oversee information provided to them.
Data collection
We anticipate that the following three rounds will allow an
acceptable degree of agreement on research priorities, but if
not, a fourth round will be undertaken. In each round, we
will ask participants to complete their questionnaires within
2 weeks, and we will send two reminder emails before the
deadline. In order to enable efficient and timely data
collection with international participants, we will use the
REDCap platform, a secure web application on server
infrastructure physically located at the University of British
Columbia University Data Centre in Canada.
○ Round 1: We will collect participants’ sociodemographic
information (e.g., country, sex, areas of expertise, primary
occupational role). For each PPI strategy included in the
preliminary list, we will ask participants to (1) rate how
relevant the strategy is to engaging women, men, or other
sex/gender categories; (2) rate how relevant the strategy is
to each of the scaling-up steps; (3) determine how relevant
the strategy is to various contexts (e.g., low-, middle-, or
high-income countries; primary, secondary, or tertiary
care); and (4) suggest any other PPI strategies required in
scaling-up initiatives in HSS. Responses will be collated and
discussed by our steering committee, and a list of strategies
will be drawn up for scoring in the following round.
○ Round 2: Participants will be asked to individually
score each PPI strategy for its overall relevance to the
largest range of sex/gender categories, scaling up steps
and contexts. In addition, they will be invited to provide
a brief justification or cite a relevant study to support
their scores. Finally, there will be an opportunity to add
any further PPI strategy that respondents feel should be
considered. We will collate results and calculate the
median score and percentage of agreement.
○ Round 3: We will send a checklist to participants who
completed the second round in which the median results
from the third round are listed alongside the participant’s
own score. Participants will be invited to reconsider the
relevance of the PPI strategies and confirm or revise their
score in the light of the participants’ opinions.
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Data analysis
We will use a 10-point Likert scale ranging from 0 =
“not relevant” to 9 = “highly relevant.” We will
categorize participants’ responses as low (0–3), moderate
(4–6), and high (7–9) [48]. For each PPI strategy, con-
sensus will be defined as 80% agreement for the priority
score of 7–9. Results will be collated using Excel to cal-
culate the median score and percentage of agreement.
Build collaboration network
We will use a snowballing recruitment method to de-
velop an international network of stakeholders who
share an interest in the field of scaling up in HSS. The
snowball method is modeled after “contact tracing” in
health, in which one individual names all other individ-
uals who were associated with a specific event [49]. We
established the RePOS network in March 2020 and in-
cluded over 20 members (e.g., patients, citizens, health
care providers, policy makers, researchers, and trainees)
from low-, middle-, and high-income countries. First,
with our steering committee members, we will define
eligibility criteria and draft an indicative electronic mem-
bership form. Second, we will email steering committee
members, our collaborators, and all Delphi study partici-
pants to ask them to become members of the RePOS
network by signing the electronic form. Also, we will ask
them to suggest other stakeholders eligible for inclusion
in the network. Third, we will use internet-based forums,
conference calls, monthly e-bulletins, and ongoing ex-
change to increase the network’s reach to other experts
in the field. We will continue to add stakeholders until
we have no new eligible names. Finally, the creation of
this group will allow us to experience all the difficulties
and complexities of involving PPI and multiple stake-
holders in a scaling-up project.
Discussion
In this project, we will identify relevant strategies for
meaningfully and equitably involving patients and the
public in the science and practice of scaling up in HSS.
Overall, outcomes will be:
1) An inventory of existing strategies related to the
involvement of patients and the public in scaling-up
initiatives in HSS. This inventory will serve as a
guide for those planning scaling up to map their
specific PPI needs;
2) A consensus on most relevant strategies for PPI in
scaling-up initiatives in HSS. Analysis of common
elements of relevant PPI strategies will provide a
generic framework for future endeavors;
3) An international network of stakeholders working in
patient-oriented research on scaling up. Overall, this
collaboration will utilize and disseminate our research
results (most effective PPI strategies for scaling up
evidence-based innovations) to ensure that more
scaling-up initiatives worldwide reflect the needs and
priorities of those they are intended to benefit.
Our project will result in a better understanding of
PPI in scaling-up initiatives in HSS, a knowledge gap
identified in previous work [6, 50]. Our project will also
contribute to knowledge about effective PPI in other
complex research projects. Our findings have the poten-
tial to increase the impact of evidence-based innovations
worldwide (including in lower- and middle-income
countries), ensure they benefit the people they are
intended for, reduce waste, and ultimately contribute to
reducing health inequities and improving the health of
populations.
We acknowledge that this project includes some oper-
ational challenges, such as restricted face-to-face interac-
tions and activities because of the coronavirus disease 2019
(COVID-19) pandemic. However, we will use teleconfer-
ence software to continue working as a team and involve
patients, citizens, and participants who are comfortable
with using these technologies. Another potential challenge
common to Delphi studies is participant dropout, but we
will maintain participant enthusiasm and engagement by
expressing our appreciation for their time in every email
correspondence, maintaining connections in person by tele-
phone, and following-up with non-respondents [51, 52].
Finally, we will disseminate our results to knowledge users
through publications in peer-reviewed journals, presenta-
tions at relevant conferences, and organization of work-
shops. We will also share our reports using free public
repositories such as Open Science Framework and
ResearchGate. The dissemination of this project will start
with the publication of the protocol. Any amendments made
to this protocol will be reported in the final manuscript.
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